MEK1/2 kinases disable the tumor suppressor functions of native BCR and ABL1 kinases to impair anticancer drugs’ responsiveness in TKI-resistant Philadelphia positive leukemias
Mazzera° L, Abeltino M, Lombardi° G, Cantoni AM, Jottini S, Corradi A, Ricca° M, Rossetti E, Armando F, Peli A, Ferrari A, Martinelli G, Scupoli MT, Visco C, Bonifacio M, Ripamonti A, Gambacorti_Passerini C, Bonati A, Perris R, Lunghi P
Congress of the Italian Society of Experimental Hematology (18th : Firenze, Italy : March 7-9, 2024)
Haematologica . – Vol. 109 s1 (2024) . – p s66-s67 (P019)
ultimo accesso 05/12/2024 https://haematologica.org/issue/view/haematol.2024.s1
Nr. Estr. 9779
